StonvexLoading…
StonvexStonvexStonvexCore line items from TSLA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $22.39B | $94.83B | $69.93B | $41.83B |
Operating Income | $941.00M | $4.36B | $2.95B | $1.32B |
Net Income | $477.00M | $3.79B | $2.95B | $1.58B |
EPS (Diluted) | $0.13 | $1.08 | $0.84 | $0.45 |
Total Assets | $143.72B | $137.81B | $133.74B | $128.57B |
Total Liabilities | $58.92B | $54.94B | $53.02B | $50.49B |
Cash & Equivalents | $16.60B | $16.51B | $18.29B | $15.59B |
Free Cash Flow OCF − CapEx | $1.44B | $6.22B | $4.80B | $810.00M |
Shares Outstanding | 3.75B | 3.75B | 3.32B | 3.22B |